Pfizer Expands Into Stem Cell Research
Lured by the promise of financial profit, the pharmaceutical giant Pfizer joins the stem cell community.
Lured by the promise of financial profit, the pharmaceutical giant Pfizer joins the stem cell community.
At the start of a major conference, the man who first introduced embryonic stem cells to the world delivers a cautionary message.
Michael West, CEO of BioTime, Inc., schedules key stem cell licensing topics for conference call.
Plans are underway at The Anthony Nolan Trust Cord Blood Bank at Nottingham Trent University in England for a major processing and storage facility of cord blood.
The combined results of two independent groups of researchers represent major progress in the development of safer, more efficiently produced iPS (induced pluripotent stem) cells.
Sir Ian Wilmut and Dr. Shinya Yamanaka are among those honored at a glittering ceremony in Hong Kong for their pioneering work.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.